The DOI matches its Crossref record.
Early Detection of Sporadic Pancreatic Cancer: Summative Review
Open accessAbstract
Pancreatic cancer (PC) is estimated to become the second leading cause of cancer death in the United States by 2020. Early detection is the key to improving survival in PC. Addressing this urgent need, the Kenner Family Research Fund conducted the inaugural Early Detection of Sporadic Pancreatic Cancer Summit Conference in 2014 in conjunction with the 45th Anniversary Meeting of the American Pancreatic Association and Japan Pancreas Society. This seminal convening of international representatives from science, practice, and clinical research was designed to facilitate challenging interdisciplinary conversations to generate innovative ideas leading to the creation of a defined collaborative strategic pathway for the future of the field. An in-depth summary of current efforts in the field, analysis of gaps in specific areas of expertise, and challenges that exist in early detection is presented within distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. In addition, an overview of efforts in familial PC is presented in an addendum to this article. It is clear from the summit deliberations that only strategically designed collaboration among investigators, institutions, and funders will lead to significant progress in early detection of sporadic PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“If the stage distribution could be reversed, to 50% localized and 10% metastatic, survival would be more than doubled without any additional improvements in therapy.3”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the currently used blood-based biomarker, CA 19-9, accurately predicts only 65% of those with early disease when surgical treatment is a viable option.3,167”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, screening in the asymptomatic population is not recommended due to the economic burden and the relatively low incidence of PC in the general population 21,22.”
From Artificial intelligence in pancreatic cancer (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Early symptoms of the disease are mostly nonspecific.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the size of the lesion at the time of surgery is a predictor of long-term survival.3,166,167”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have shown that early detection of PDAC improves outcome.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“This result is based on the findings that surgery is the only therapy to date associated with a durable long-term outcome.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
In the citing paper
“a multitude of circulating tumor-derived analytes (proteins, autoantibodies, metabolites, DNA, non-coding RNAs and extracellular vesicles, among others) have been assessed in the context of PDAC early detection39–41.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Research works printed but not linked: 1
- References are available online at: http://links.lww.com/MPA/A374.
Cited by
Sorted by citations
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X. O., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,697
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Self-citationLin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts
Elta, G. H., Enestvedt, B. K., Sauer, B. G., & Lennon, A. M. (2018) · The American Journal of Gastroenterology · doi:10.1038/ajg.2018.14 · Cited by 734
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
Notta, F., Chan-Seng-Yue, M., Lemire, M., Li, Y., Wilson, G. W., Connor, A. A., Denroche, R. E., Liang, S.-B., Brown, A. M. K., Kim, J. C., et al. (2016) · Nature · doi:10.1038/nature19823 · Cited by 528
Self-citationUS Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.10232 · Cited by 419
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
Bengtsson, A., Andersson, R. E., & Ansari, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-73525-y · Cited by 427
Pancreatic Cancer: Yesterday, Today and Tomorrow
Ansari, D., Tingstedt, B., Andersson, B., Holmquist, F., Sturesson, C., Williamsson, C., Sasor, A., Borg, D., Bauden, M. P., & Andersson, R. E. (2016) · Future Oncology · doi:10.2217/fon-2016-0010 · Cited by 399
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
Kim, J., Bamlet, W. R., Oberg, A. L., Chaffee, K. G., Donahue, G., Cao, X.-J., Chari, S., Garcia, B. A., Petersen, G. M., & Zaret, K. S. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5583 · Cited by 269
Self-citationEarly detection of pancreatic cancer: Where are we now and where are we going?
Zhou, B., Xu, J., Cheng, Y., Gao, J., Hu, S., Wang, L., & Zhan, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30670 · Cited by 218
Gabitova-Cornell, L., Surumbayeva, A., Peri, S., Franco‐Barraza, J., Restifo, D., Weitz, N., Ogier, C., Goldman, A. R., Hartman, T. R., Francescone, R., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.015 · Cited by 206
Sharma, A., Smyrk, T. C., Levy, M. J., Topazian, M. A., & Chari, S. T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.025 · Cited by 204
Self-citationBoursi, B., Finkelman, B., Giantonio, B. J., Haynes, K., Rustgi, A. K., Rhim, A. D., Mamtani, R., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.046 · Cited by 202
Self-citationEvaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Stoffel, E. M., McKernin, S. E., Brand, R. E., Canto, M. I., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M. B. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01489 · Cited by 205
Self-citationSerum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer
Mellby, L. D., Nyberg, A. P., Johansen, J. S., Wingren, C., Nordestgaard, B. G., Bojesen, S. E., Mitchell, B. L., Sheppard, B. C., Sears, R. C., & Borrebaeck, C. A. K. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6658 · Cited by 159
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158
Self-citationJailkhani, N., Ingram, J. R., Rashidian, M., Rickelt, S., Tian, C., Mak, H. H., Jiang, Z.-G., Ploegh, H. L., & Hynes, R. O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817442116 · Cited by 156
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
Capello, M., Bantis, L. E., Scélo, G., Zhao, Y., Peng, L., Dhillon, D. S., Patel, N. J., Kundnani, D. L., Wang, H., Abbruzzese, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw266 · Cited by 148
Self-citationHenrikson, N. B., Aiello Bowles, E. J., Blasi, P. R., Morrison, C. C., Nguyen, M., Pillarisetty, V. G., & Lin, J. S. (2019) · JAMA · doi:10.1001/jama.2019.6190 · Cited by 140
Artificial intelligence in pancreatic cancer
Huang, B., Huang, H., Zhang, S., Zhang, D., Shi, Q., Liu, J., & Guo, J. (2022) · Theranostics · doi:10.7150/thno.77949 · Cited by 142
“recommended due to the economic burden and the relatively low incidence of PC in the general population [21,22].”
BackgroundPaparrizos, J., White, R. W., & Horvitz, E. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.010504 · Cited by 132
Grünwald, B. T., Harant, V., Schaten, S., Frühschütz, M., Spallek, R., Höchst, B., Stutzer, K., Berchtold, S., Erkan, M., Prokopchuk, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.043 · Cited by 133
Méndez, R., Kesh, K., Arora, N., Martino, L. D., McAllister, F. M., Merchant, N. B., Banerjee, S., & Banerjee, S. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz116 · Cited by 125
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Feng, L., Qi, Q., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Journal of International Medical Research · doi:10.1177/0300060518800588 · Cited by 113
The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families
Pilarski, R. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238977 · Cited by 115
Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.44 · Cited by 102
Banaei, N., Moshfegh, J., Mohseni-Kabir, A., Houghton, J. M., Sun, Y., & Kim, B. G. (2019) · RSC Advances · doi:10.1039/c8ra08930b · Cited by 101
Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon
Petrov, M. S. (2017) · Pancreatology · doi:10.1016/j.pan.2017.06.007 · Cited by 98
Maitra, A., Sharma, A., Brand, R. E., Van Den Eeden, S. K., Fisher, W. E., Hart, P. A., Hughes, S. J., Mather, K. J., Pandol, S. J., Park, W. G., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001169 · Cited by 93
Self-citationVolatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine
Daulton, E., Wicaksono, A. N., Tiele, A., Kocher, H. M., Debernardi, S., Crnogorac‐Jurcevic, T., & Covington, J. A. (2020) · Talanta · doi:10.1016/j.talanta.2020.121604 · Cited by 93
Setiawan, V. W., Stram, D. O., Porcel, J., Chari, S. T., Maskarinec, G., Le Marchand, L., Wilkens, L. R., Haiman, C. A., Pandol, S. J., & Monroe, K. R. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy090 · Cited by 91
Self-citationDimastromatteo, J., Brentnall, T. A., & Kelly, K. A. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.144 · Cited by 92
Self-citationGao, Y., Zhu, Y., Zhang, Z., Zhang, C., Huang, X., & Yuan, Z. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0340-0 · Cited by 89
Endoscopic ultrasound (EUS) and the management of pancreatic cancer
Yousaf, M. N., Chaudhary, F. S., Ehsan, A., Suarez, A. L., Muniraj, T., Jamidar, P. A., Aslanian, H. R., & Farrell, J. J. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000408 · Cited by 81
Exploiting pancreatic cancer metabolism: challenges and opportunities
Santis, M. C. D., Bockorny, B., Hirsch, E., Cappello, P., & Martini, M. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.03.008 · Cited by 85
A Systematic Review of Intra-pancreatic Fat Deposition and Pancreatic Carcinogenesis
Sreedhar, U. L. S., DeSouza, S. V., Park, B., & Petrov, M. S. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04417-4 · Cited by 76
Korfiatis, P. D., Suman, G., Patnam, N. G., Trivedi, K. H., Karbhari, A., Mukherjee, S., Cook, C. J., Klug, J. R., Patra, A., Khasawneh, H., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.08.034 · Cited by 79
Self-citationGlypican-1 in exosomes as biomarker for early detection of pancreatic cancer.
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.39 · Cited by 67
Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers
Kenner, B. J., Chari, S. T., Maitra, A., Srivastava, S., Cleeter, D. F., Go, V. L. W., Rothschild, L. J., & Goldberg, A. E. (2016) · Pancreas · doi:10.1097/mpa.0000000000000701 · Cited by 67
Self-citationA Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
Balasenthil, S., Huang, Y., Liu, S., Marsh, T. L., Chen, J., Stass, S. A., Kukuruga, D. L., Brand, R. E., Chen, N., Frazier, M. L., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw341 · Cited by 69
Self-citationCurrent Approaches to Pancreatic Cancer Screening
Chhoda, A., Lu, L., Clerkin, B. M., Risch, H. A., & Farrell, J. J. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.013 · Cited by 64
Klett, H., Füllgraf, H., Levit‐Zerdoun, E., Hussung, S., Kowar, S., Küsters, S., Bronsert, P., Werner, M., Wittel, U. A., Fritsch, R., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00108 · Cited by 62
Chari, S. T., Maitra, A., Matrisian, L. M., Shrader, E. E., Wu, B. U., Kambadakone, A., Zhao, Y.-Q., Kenner, B., Rinaudo, J. A. S., Srivastava, S., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106659 · Cited by 62
Self-citationOptimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping
Luo, G., Guo, M., Jin, K., Liu, Z., Liu, C., Cheng, H., Yu, L., Long, J., Liu, L., Xu, J., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.09.013 · Cited by 61
Boroujeni, A. M., Yousefi, E., & Somma, J. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21915 · Cited by 60
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Pourali, G., Kazemi, D., Chadeganipour, A. S., Arastonejad, M., Kashani, S. N., Pourali, R., Maftooh, M., Akbarzade, H., Fiuji, H., Hassanian, S. M., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-023-03166-4 · Cited by 64
Honda, K., Katzke, V. A., Hüsing, A., Okaya, S., Shoji, H., Onidani, K., Olsen, A., Tjønneland, A. M., Overvad, K., Weiderpass, E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31900 · Cited by 60
Early Detection of Pancreatic Cancer
Kenner, B. J., Abrams, N., Chari, S. T., Field, B. F., Goldberg, A. E., Hoos, W. A., Klimstra, D. S., Rothschild, L. J., Srivastava, S., Young, M. R., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001882 · Cited by 63
Self-citationEarly Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper
Kenner, B. J., Chari, S. T., Cleeter, D. F., & Go, V. L. W. (2015) · Pancreas · doi:10.1097/mpa.0000000000000369 · Cited by 56
Self-citationYAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice
Park, J., Eisenbarth, D., Choi, W., Kim, H., Choi, C., Lee, D., & Lim, D. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0907 · Cited by 59
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas
Hill, W., Ζαραγκούλιας, Α., Salvador-Barberó, B., Parfitt, G. J., Alatsatianos, M., Padilha, A., Porazinski, S. R., Woolley, T. E., Morton, J. P., Sansom, O. J., et al. (2021) · Current Biology · doi:10.1016/j.cub.2021.03.094 · Cited by 55
Pancreatic cancer as a sentinel for hereditary cancer predisposition
Young, E. L., Thompson, B. A., Neklason, D. W., Snow, A. K., Firpo, M. A., Werner, T. L., Bell, R., Sutherland, N., Smith, K. R., Berger, J., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4573-5 · Cited by 56
Self-citationLam, B., Shrivastava, S. K., Shrivastava, A., Shankar, S., & Srivastava, R. K. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15413 · Cited by 53
Early Detection of Pancreatic Cancer
Kenner, B. J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001024 · Cited by 53
Self-citationKirkegård, J., Gaber, C. E., Lund, J. L., Hinton, S. P., Ladekarl, M. B., Heide‐Jørgensen, U., Cronin-Fenton, D. P., & Mortensen, F. V. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101647 · Cited by 52
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
Yin, H., Wang, L., & Liu, H. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/3842198 · Cited by 52
Exosomes in Pancreatic Cancer: from Early Detection to Treatment
Armstrong, E. A., Beal, E. W., Chakedis, J. M., Paredes, A. Z., Moris, D., Pawlik, T. M., Schmidt, C. R., & Dillhoff, M. E. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3693-1 · Cited by 52
Khalaf, N. I., Yuan, C., Hamada, T., Cao, Y., Babić, A., Morales‐Oyarvide, V., Kraft, P. L., Ng, K., Giovannucci, E. L., Ogino, S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.12.001 · Cited by 50
S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
Bydoun, M., Sterea, A. M., Liptay, H., Uzans, A., Huang, W., Rodrigues, G. J., Weaver, I. C. G., Gu, H., & Waisman, D. M. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12356 · Cited by 49
Exosomes: Potential for Early Detection in Pancreatic Cancer
Lu, L., & Risch, H. A. (2016) · Future Oncology · doi:10.2217/fon-2015-0005 · Cited by 49
Aronsson, L., Bengtsson, A., Torén, W., Andersson, R. E., & Ansari, D. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.09.014 · Cited by 47
Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know
Buerlein, R. C. D., & Shami, V. M. (2021) · Therapeutic Advances in Gastrointestinal Endoscopy · doi:10.1177/26317745211045769 · Cited by 49
Wang, L., Bi, R., Yin, H., Liu, H., & Li, L. (2019) · PubMed · Cited by 46
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Kung, H., & Yu, J. (2023) · MedComm · doi:10.1002/mco2.216 · Cited by 44
Brand, R. E., Persson, J., Bratlie, S. O., Chung, D. C., Katona, B. W., Carrato, A., Castillo, M., Earl, J., Kokkola, A., Lucas, A. L., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000468 · Cited by 46
Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
Lee, H. S., Jang, C. Y., Kim, S. A., Park, S. B., Jung, D. E., Kim, B. O., Kim, H. Y., Chung, M. J., Park, J. Y., Bang, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21823-x · Cited by 44
Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma
Ermiah, E., Eddfair, M. M., Abdulrahman, O., Elfagieh, M. A., Jebriel, A. O., Al‐Sharif, M., Assidi, M., & Buhmeida, A. S. (2022) · Molecular and Clinical Oncology · doi:10.3892/mco.2022.2559 · Cited by 43
Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review
Jan, Z., Assadi, F. E., Abd-Alrazaq, A. A., & Jithesh, P. V. (2023) · Journal of Medical Internet Research · doi:10.2196/44248 · Cited by 41
Tang, H., Partyka, K. A., Hsueh, P. Y., Sinha, J. Y., Kletter, D., Zeh, H. J., Huang, Y., Brand, R. E., & Haab, B. B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.12.003 · Cited by 41
Bušek, P., Vaníčková, Z., Hrabal, P., Brabec, M., Fric, P., Zavoral, M., Škrha, J., Kmochová, K., Laclav, M., Bunganič, B., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.06.001 · Cited by 42
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
Debernardi, S., Blyuss, O. B., Rycyk, D., Srivastava, K., Jeon, C. Y., Cai, H., Cai, Q., Shu, X., & Crnogorac‐Jurcevic, T. (2022) · International Journal of Cancer · doi:10.1002/ijc.34287 · Cited by 39
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma
Habib, J. R., Kinny‐Köster, B., Bou‐Samra, P., Alsaad, R., Sereni, E., Javed, A. A., Ding, D., Cameron, J. L., Lafaro, K. J., Burns, W. R., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004915 · Cited by 40
Ma, Y., Yu, W., Shrivastava, A., Srivastava, R. K., & Shankar, S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14178 · Cited by 39
Rodríguez, E., Boelaars, K., Brown, K., Madunić, K., van Ee, T., Dijk, F., Verheij, J., Li, R. J. E., Schetters, S. T. T., Meijer, L. L., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02934-0 · Cited by 38
Xing, L., Li, X., Xing, Z., Li, F., Shen, M., Wang, H., Shi, X., & Du, L. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.122949 · Cited by 37
Maharaj, A. D., Evans, S., Zalcberg, J. R., Ioannou, L., Graco, M., Croagh, D. G., Pilgrim, C. H. C., Dodson, T., Goldstein, D., Philip, J. A. M., et al. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-011793 · Cited by 37
Giannis, D., Moris, D., & Barbas, A. S. (2021) · Cancers · doi:10.3390/cancers13051071 · Cited by 37
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6071 · Cited by 35
Honda, K., & Srivastava, S. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0209 · Cited by 36
Self-citationPancreatic cancer and associated exosomes
Zhao, C., Gao, F., Weng, S., & Liu, Q. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170258 · Cited by 34
Chang, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030692 · Cited by 38
Jia, E., Ren, N., Shi, X., Zhang, R., Yu, H., Yu, F., Qin, S., & Xue, J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09463-x · Cited by 36
Familial Pancreatic Cancer and the Future of Directed Screening
Welinsky, S., & Lucas, A. L. (2017) · Gut and Liver · doi:10.5009/gnl16414 · Cited by 33
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
Root, A., Allen, P. J., Tempst, P., & Yu, K. H. (2018) · Cancers · doi:10.3390/cancers10030067 · Cited by 33
Gallo, M., Adinolfi, V., Morviducci, L., Acquati, S., Tuveri, E., Ferrari, P., Zatelli, M. C., Faggiano, A., Argentiero, A., Natalicchio, A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100155 · Cited by 33
Preoperative Evaluation of Pancreatic Fibrosis and Lipomatosis
Schawkat, K., Eshmuminov, D., Lenggenhager, D. M., Endhardt, K., Vrugt, B., Boss, A., Petrowsky, H., Clavien, P., & Reiner, C. S. (2018) · Investigative Radiology · doi:10.1097/rli.0000000000000496 · Cited by 31
Exosomes and pancreatic diseases: status, challenges, and hopes
Guo, X., Xiao, F., Li, J., Zhou, Y., Zhang, W.-J., Sun, B., & Wang, G. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.35823 · Cited by 30
Rasuleva, K., Elamurugan, S., Bauer, A., Khan, M., Wen, Q., Li, Z., Steen, P. D., Guo, A., Xia, W., Mathew, S., et al. (2021) · ACS Sensors · doi:10.1021/acssensors.1c02022 · Cited by 31
Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
Mazza, T., Gioffreda, D., Fontana, A., Biagini, T., Carella, M., Palumbo, O., Maiello, E., Bazzocchi, F., Andriulli, A., & Tavano, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00044 · Cited by 29
Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
Dong, Y., Shi, Y., He, L., Cui, X.-Y., & Su, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18233 · Cited by 28
Hidayat, K., Zhou, Y., Du, H., Qin, L., Shi, B., & Li, Z. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5550 · Cited by 30
B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma
Zhao, J., Meng, Z., Xie, C. L., Yang, C., Liu, Z., Wu, S., Wang, B., Fan, P., Jin, X., & Wu, H. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.011 · Cited by 28
BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug
Fujimoto, T., Teraishi, F., Kanehira, N., Tajima, T., Sakurai, Y., Kondo, N., Yamagami, M., Kuwada, A., Morihara, A., Kitamatsu, M., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122605 · Cited by 27
Sato, K., Hikita, H., Myojin, Y., Fukumoto, K., Murai, K., Sakane, S., Tamura, T., Yamai, T., Nozaki, Y., Yoshioka, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235573 · Cited by 26
Maire, F., Cibot, J.-O., Compagne, C., Hentic, O., Hammel, P. R., Müller, N., Ponsot, P., Lévy, P., & Ruszniewski, P. B. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000901 · Cited by 25
Choi, M. H., Mejlænder-Andersen, E., Manueldas, S., Jellas, K. E., Steine, S. J., Tjensvoll, K., Sætran, H. A., Knappskog, S., Hoem, D., Nordgård, O., et al. (2019) · BMC Cancer · doi:10.1186/s12885-018-5195-7 · Cited by 26
Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers
Kenner, B. J., Go, V. L. W., Chari, S. T., Goldberg, A. E., & Rothschild, L. J. (2017) · Pancreas · doi:10.1097/mpa.0000000000000939 · Cited by 24
Self-citationPlasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma
Yu, J., Ploner, A., Kordes, M., Löhr, M. J., Nilsson, M., de Maturana, M. E. L., Estudillo, L., Renz, H. E., Carrato, A., Molero, X., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33464 · Cited by 24
Zhuang, L., Huang, C., Ning, Z., Yang, L., Zou, W., Wang, P., Cheng, C., & Meng, Z. (2022) · International Journal of Cancer · doi:10.1002/ijc.34334 · Cited by 24
Metadata
- Authors
- Chari, S. T., Kelly, K., Hollingsworth, M. A., Thayer, S. P., Ahlquist, D. A., Andersen, D. K., Batra, S. K., Brentnall, T. A., Canto, M., Cleeter, D. F., Firpo, M. A., Gambhir, S. S., Go, V. L. W., Hines, O. J., Kenner, B. J., Klimstra, D. S., Lerch, M. M., Levy, M. J., Maitra, A., Mulvihill, S. J., Petersen, G. M., Rhim, A. D., Simeone, D. M., Srivastava, S., Tanaka, M., Vinik, A. I., & Wong, D.
- Affiliations
- Mayo Clinic (US)
- Eastern Virginia Medical School (US)
- University of California, Los Angeles (US)
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Chari, Suresh T.
- Ahlquist, David A.
- Canto, Marcia
- Klimstra, David S.
- Tanaka, Masao
- ORCID
- Chari, Suresh T.
- Hollingsworth, Michael A.
- Thayer, Sarah P.
- Ahlquist, David A.
- Andersen, Dana K.
- Batra, Surinder K.
- Brentnall, Teresa A.
- Canto, Marcia
- Firpo, Matthew A.
- Gambhir, Sanjiv Sam
- Hines, O. Joe
- Kenner, Barbara J.
- Klimstra, David S.
- Lerch, Markus M.
- Levy, Michael J.
- Maitra, Anirban
- Mulvihill, Sean J.
- Petersen, Gloria M.
- Rhim, Andrew D.
- Simeone, Diane M.
- Srivastava, Sudhir
- Tanaka, Masao
- Vinik, Aaron I.
- Venue
- Pancreas
- Published
- 2015-07
- Volume
- 44
- Issue
- 5
- Pages
- 693-712
- ISSN
- 0885-3177 (ISSN-L)
- PMC
- PMC4467589
- OpenAlex
- W2064141899
- Cited by
- 295
- References
- 0
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 34 · 2021: 35 · 2020: 28 · 2019: 30 · 2018: 30 · 2017: 31 · 2016: 30 · 2015: 8
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Pancreas (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (P50CA102701, R01CA168712, R01CA177857)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- pancreatic cancer, early detection, biomarkers, pancreatic imaging, familial pancreatic cancer, cancer survival, interdisciplinary collaboration, research gaps
- MeSH terms
- Biopsy, Congresses as Topic, Cooperative Behavior, Diagnostic Imaging, Diffusion of Innovation, Humans, International Cooperation, Pancreatic Neoplasms, Predictive Value of Tests, Prognosis, Biomarkers, Tumor, Survival Analysis, Carcinoma, Pancreatic Ductal, Molecular Diagnostic Techniques, Interdisciplinary Communication, Biomedical Research, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
